Correlation Between Eledon Pharmaceuticals and OrganiGram Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eledon Pharmaceuticals and OrganiGram Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eledon Pharmaceuticals and OrganiGram Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eledon Pharmaceuticals and OrganiGram Holdings, you can compare the effects of market volatilities on Eledon Pharmaceuticals and OrganiGram Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eledon Pharmaceuticals with a short position of OrganiGram Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eledon Pharmaceuticals and OrganiGram Holdings.

Diversification Opportunities for Eledon Pharmaceuticals and OrganiGram Holdings

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Eledon and OrganiGram is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Eledon Pharmaceuticals and OrganiGram Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OrganiGram Holdings and Eledon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eledon Pharmaceuticals are associated (or correlated) with OrganiGram Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OrganiGram Holdings has no effect on the direction of Eledon Pharmaceuticals i.e., Eledon Pharmaceuticals and OrganiGram Holdings go up and down completely randomly.

Pair Corralation between Eledon Pharmaceuticals and OrganiGram Holdings

Given the investment horizon of 90 days Eledon Pharmaceuticals is expected to generate 2.02 times more return on investment than OrganiGram Holdings. However, Eledon Pharmaceuticals is 2.02 times more volatile than OrganiGram Holdings. It trades about 0.14 of its potential returns per unit of risk. OrganiGram Holdings is currently generating about -0.25 per unit of risk. If you would invest  349.00  in Eledon Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of  58.00  from holding Eledon Pharmaceuticals or generate 16.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Eledon Pharmaceuticals  vs.  OrganiGram Holdings

 Performance 
       Timeline  
Eledon Pharmaceuticals 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Eledon Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Eledon Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.
OrganiGram Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OrganiGram Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Eledon Pharmaceuticals and OrganiGram Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eledon Pharmaceuticals and OrganiGram Holdings

The main advantage of trading using opposite Eledon Pharmaceuticals and OrganiGram Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eledon Pharmaceuticals position performs unexpectedly, OrganiGram Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OrganiGram Holdings will offset losses from the drop in OrganiGram Holdings' long position.
The idea behind Eledon Pharmaceuticals and OrganiGram Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk